140 related articles for article (PubMed ID: 17517527)
1. Expression of cyclooxygenase-2 in canine nasal carcinomas.
Impellizeri JA; Esplin DG
Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
[TBL] [Abstract][Full Text] [Related]
2. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
Borzacchiello G; Russo V; Russo M
J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
Borzacchiello G; Paciello O; Papparella S
J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
[TBL] [Abstract][Full Text] [Related]
7. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
8. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.
Smith KM; Scase TJ; Miller JL; Donaldson D; Sansom J
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():8-14. PubMed ID: 19046264
[TBL] [Abstract][Full Text] [Related]
10. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
[TBL] [Abstract][Full Text] [Related]
12. Nasal and paranasal adenocarcinomas with neuroendocrine differentiation in dogs.
Ninomiya F; Suzuki S; Tanaka H; Hayashi S; Ozaki K; Narama I
Vet Pathol; 2008 Mar; 45(2):181-7. PubMed ID: 18424830
[TBL] [Abstract][Full Text] [Related]
13. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas.
Paciello O; Borzacchiello G; Varricchio E; Papparella S
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580
[TBL] [Abstract][Full Text] [Related]
15. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.
Mutsaers AJ; Mohammed SI; DeNicola DB; Snyder PW; Glickman NW; Bennett PF; de Gortari AE; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):181-6. PubMed ID: 15664302
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
[TBL] [Abstract][Full Text] [Related]
19. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
Prada J; Queiroga FL; Gregório H; Pires I
J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]